CTIS2024-511915-21-01进行中（未招募）1 期
The TILS001 trial
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer0 个研究点目标入组 20 人开始时间: 2024年6月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Phase I trial: PXL 272092ISRCTN45338135Hansa Biopharma (Sweden)8
进行中（未招募）
1 期
Phase I trial - 2021-006930-37The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has endedISRCTN15751828Omeros Corporation (United States)12
已完成
不适用
A single-center, open pilot trial to investigate the performance of the modified intravascular microdialysis probe MicroEye® in healthy subjectsHealthy SubjectsDRKS00015049A. Menarini Diagnostics S.r.l.20
终止
1 期
A study to determine the safety and maximum tolerable dose of LTI-01 in patients who has pneumonia-like symptoms with a build up of fluid in their lungsACTRN12616001442493Clinical Network Services Pty Ltd21
招募中
不适用
A phase I trial of intravenously administered M6229 in critically ill sepsis patientsNL-OMON23213Amsterdam UMC, location AMC16